Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ACTRN12626000927325) titled 'Prospective value of the Genea natural killer cell activity (NKa) blood test and its extended panels on live birth rate in women under 40 years doing In vitro fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) or frozen embryo transfer cycles' on July 28.
Study Type: Observational
Study Design:
Purpose: Screening
Duration: Longitudinal
Selection: Defined population
Timing: Prospective
Primary Sponsor: Professor Gavin Sacks - Flow fertility with Genea
Condition:
Pregnancy rate
Pregnancy rate
Reproductive Health and Childbirth - Fertility including in vitro fertilisation
Intervention:
Participants w...